Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about MRK

Recent news which mentions MRK

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
32 33 Next >
Unpacking the Latest Options Trading Trends in Merck & Co
Tickers MRK
Tags BZI/UOA Market News Options
From Benzinga
Merck Buys WuXi Vaccines' Irish Manufacturing Facility For Over $500 Million
Tickers MRK NEWS
Tags Health Care Market News Contracts
From Benzinga
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
Tickers GPCR LLY MRK NEWS
Tags weight loss drugs Analyst Color Weight Loss
From Benzinga
Why Viking Therapeutics Stock Plummeted by 24% in December
Tickers MRK VKTX
Tags VKTX Market News Recent Press Releases
From Motley Fool
Should You Buy the Dip on This High-Flying Stock?
Tickers MRK VKTX
Tags Recent Press Releases VKTX Market News
From Motley Fool
UK Approves Merck's Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal
Tickers MRK NEWS
Tags Briefs Biotech Benzinga
From Benzinga
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
Tickers AMGN AMZN BA CSCO
Tags PG DOW Benzinga
From Benzinga
2 High-Yield Dividend Stocks to Buy Early in 2025
Tickers BMY MRK
Tags Market News Recent Press Releases MRK
From Motley Fool
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
Tickers GS LLY MRK NVDA
Tags LLY WMT NVS
From Motley Fool
3 Stocks That Could Be Monster Winners in 2025
Tickers MRK NVO SMMT VKTX
Tags NVO Recent Press Releases VKTX
From Motley Fool
2 Reasons to Sell Merck Stock and 1 Reason to Buy
Tickers MRK
Tags Market News Recent Press Releases MRK
From Motley Fool
Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025
Tickers AMZN CAT CRM CVX
Tags Tigress Financial HES Ivan Feinseth
From Benzinga
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Tickers ABBV BMY ELAN GILD
Tags Analyst Color TEVA MRK
From Benzinga
Is Merck the Next Big Weight-Loss Stock?
Tickers LLY MRK NVO
Tags MRK Recent Press Releases LLY
From Motley Fool
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?
Tickers MRK VKTX
Tags MRK VKTX Market News
From Motley Fool
Why Viking Therapeutics Tumbled by More Than 10% This Week
Tickers LLY MRK NVO VKTX
Tags LLY Recent Press Releases NVO
From Motley Fool
Want to Collect a Dividend Every Month? Invest in These 3 High-Yielding Income Stocks
Tickers CVX MRK T
Tags CVX MRK Market News
From Motley Fool
3 Stocks That Could Turn $1,000 into $5,000 by 2030
Tickers GOOG GOOGL MRK MRNA
Tags GOOGL MRNA WRD
From Motley Fool
Merck's Investigational Two-Drug Regime For HIV Meets Primary Goal In Two Late-Stage Trials
Tickers MRK NEWS
Tags Large Cap Benzinga Biotech
From Benzinga
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Tickers BMY CI CNC CVS
Tags DGX Government UNH
From Benzinga
Stock Of The Day: Where Does The Merck Downtrend End?
Tickers HNSPF MRK PSNL
Tags Technicals MRK Stories That Matter
From Benzinga
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Tickers MRK NEWS RHHBY SNY
Tags Expert Ideas disease News
From Benzinga
What's Going On With Viking Therapeutics Stock On Wednesday?
Tickers MRK NEWS VKTX
Tags Health Care M&A Trading Ideas
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers CI CRDF HIMS LLY
Tags Market News CI PEN
From Benzinga
What's Going On With Merck Shares Wednesday?
Tickers MRK NEWS
Tags Movers News Market News
From Benzinga
Merck Discontinues Certain Cancer Candidate Trials After Futility Analysis
Tickers MRK NEWS
Tags Market News Health Care News
From Benzinga
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Tickers AMGN AZN BMY EXEL
Tags Health Care AMGN AZN
From Benzinga
Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients
Tickers BCYC MRK NEWS
Tags MRK Stories That Matter Top Stories
From Benzinga
These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over
Tickers AMGN BA DJI JNJ
Tags BA MRK Recent Press Releases
From Motley Fool
AstraZeneca-Merck Partnered Lynparza Shows Long-Term Survival With Reduced Death Risk Of 28% In Breast Cancer Patients
Tickers AZN MRK NEWS
Tags Health Care AZN Biotech
From Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.